Moderna, Inc. - Common Stock (MRNA)

CUSIP: 60770K107

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
388,311,585
Total 13F shares
278,813,548
Share change
+1,847,556
Total reported value
$7,903,142,271
Put/Call ratio
131%
Price per share
$28.35
Number of holders
678
Value change
-$59,165,632
Number of buys
336
Number of sells
325

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 60770K107?
CUSIP 60770K107 identifies MRNA - Moderna, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
10%
40,323,750
$1,676,661,525 31 Dec 2024
13F
BAILLIE GIFFORD & CO
13F
Company
10%
38,889,571
$1,617,028,362 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
6.6%
25,791,947
$1,072,429,159 31 Dec 2024
13F
FMR LLC
13F
Company
4.8%
18,664,634
$776,075,473 31 Dec 2024
13F
STATE STREET CORP
13F
Company
4.5%
17,577,236
$730,669,796 31 Dec 2024
13F
Theleme Partners LLP
13F
Company
1.9%
7,306,861
$303,819,280 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
7,241,354
$300,219,344 31 Dec 2024
13F
UBS Group AG
13F
Company
1.3%
5,073,371
$210,950,768 31 Dec 2024
13F
Invesco Ltd.
13F
Company
1.3%
5,006,462
$208,168,697 31 Dec 2024
13F
Flagship Pioneering, LLC
13F
Company
1.2%
4,632,149
$192,604,755 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
1.1%
4,247,698
$176,619,380 31 Dec 2024
13F
NORGES BANK
13F
Company
1%
3,940,194
$163,833,267 31 Dec 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1%
3,915,092
$162,789,526 31 Dec 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.93%
3,615,060
$150,314,195 31 Dec 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.92%
3,585,966
$149,104,464 31 Dec 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.86%
3,341,924
$138,957,188 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.85%
3,301,735
$137,286,090 31 Dec 2024
13F
BANQUE PICTET & CIE SA
13F
Company
0.81%
3,132,974
$130,269,059 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.76%
2,959,054
$123,037,466 31 Dec 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.67%
2,590,831
$107,726,753 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.6%
2,344,203
$97,471,968 31 Dec 2024
13F
Merck & Co., Inc.
13F
Company
0.59%
2,308,190
$95,974,540 31 Dec 2024
13F
Legal & General Group Plc
13F
Company
0.56%
2,157,121
$89,693,089 31 Dec 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.55%
2,123,708
$88,303,779 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.49%
1,894,075
$78,755,637 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.49%
1,884,214
$78,345,620 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.46%
1,768,715
$73,543,170 31 Dec 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.45%
1,766,398
$73,446,829 31 Dec 2024
13F
CITIGROUP INC
13F
Company
0.44%
1,691,205
$70,320,304 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.43%
1,669,287
$69,343,871 31 Dec 2024
13F
Bellevue Group AG
13F
Company
0.41%
1,600,877
$66,564,466 31 Dec 2024
13F
CAPITAL FUND MANAGEMENT S.A.
13F
Company
0.35%
1,371,558
$57,029,381 31 Dec 2024
13F
Amundi
13F
Individual
0.31%
1,206,273
$52,074,805 31 Dec 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.32%
1,238,017
$51,476,747 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.31%
1,195,939
$49,727,147 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
1,128,868
$46,938,331 31 Dec 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.28%
1,073,055
$44,618,000 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.26%
1,010,758
$42,027,318 31 Dec 2024
13F
LETKO, BROSSEAU & ASSOCIATES INC
13F
Company
0.24%
923,345
$38,392,685 31 Dec 2024
13F
Swiss National Bank
13F
Company
0.24%
923,000
$38,378,340 31 Dec 2024
13F
Squarepoint Ops LLC
13F
Company
0.23%
892,868
$37,125,451 31 Dec 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.2%
783,584
$32,582,000 31 Dec 2024
13F
Douglas Lane & Associates, LLC
13F
Company
0.2%
773,804
$32,174,770 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.2%
771,892
$32,095,269 31 Dec 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.19%
755,691
$31,421,632 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.19%
745,861
$31,012,910 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.17%
672,179
$27,949,203 31 Dec 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.17%
668,467
$27,794,850 31 Dec 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.17%
664,040
$27,610,783 31 Dec 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.17%
652,564
$26,963,194 31 Dec 2024
13F

Institutional Holders of Moderna, Inc. - Common Stock (MRNA) as of Q1 2025

As of 31 Mar 2025, Moderna, Inc. - Common Stock (MRNA) was held by 678 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 278,813,548 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., BAILLIE GIFFORD & CO, FMR LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Theleme Partners LLP, UBS Group AG, and Invesco Ltd.. This page lists 683 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
729
Q1 2025 holders
678
Holder diff
-51
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.